SARS CoV-2 (COVID-19) Serology

Point of Care External Quality Assurance

The RCPAQAP is pleased to announce the release of the Point of Care External Quality Assurance Program for COVID-19 serology (IgG/IgM) devices.

Key Features:

  • Allows for post market surveillance of all SARS CoV-2 (COVID-19) serology point of care devices
  • Results can be submitted from any smart device
  • Assessment provided in real time
  • Dedicated team to assist in trouble-shooting
  • Meets regulatory framework requirements for external quality assurance testing
  • Allows for the monitoring of lot numbers and users
  • Organisations are able to review results across multiple sites
  • Facilitates competency assessment of users
  • Certificate of Completion is provided

Quote Request - SARS CoV-2 (COVID-19) Serology

Fill in the fields below and we will get back to you with a quote in the next couple of days.